Thanks to the collaborative support of the Korean Association of Liver Cancer, we are thrilled to announce that Seoul was chosen for this edition of the ILCA School of Liver Cancer.
The ILCA School is a unique learning platform for practitioners and investigators to receive education in an intense, interactive, and multidisciplinary format. This one-day ILCA School covers the latest developments in liver cancer research and treatment, including updates on tumour biology, clinical trial advances, and expert insights on management strategies. Additionally, we will help to enhance your research tools, such as oral presentation and statistical interpretation skills. Join us for a productive and engaging meeting!
Grant
The ILCA School of Liver Cancer 2024 is supported by an unrestricted educational grant from Bayer
Where
Seoul National University College of Medicine (Seoul National University Hospital)
(8) Integrative Biomedical Education Research Building
Address: 103 Daehak-ro, Jongno-gu Seoul (03080)